Fundamentals in Urology (2016)

June 11, 2016 to June 14, 2016

The Fundamentals in Urology course is designed to apply basic science knowledge and principles in development of treatment algorithms. This 4-day course will provide attendees with valuable skills in developing a rational methodological approach to application of knowledge which will contribute to positive outcomes for patients. Attendees will discover the importance of the study of basic sciences and how it transfers into the lifelong learning process and medical practice. This course is designed to ensure a fundamental knowledge of the "why" behind a broad expanse of general urologic conditions. A thorough knowledge of the basic science behind the treatments will allow for better counseling and education of patients by all clinical urologic practitioners.

    Target Audience

    • Urology residents
    • Allied Health Professionals

    Learning Objectives

    At the conclusion of this course, participants should be able to:

    1. Identify specific applications of basic science knowledge and principles in development of treatment methods
    2. Develop a scientific and methodological approach to the application of knowledge gained at the conference that is consistent with AUA guidelines and best practices
    3. Compare newly published findings and their impact on medical practice and patient care
    4. Transfer continuing study of basic sciences into lifelong learning process and medical practice
    5. Articulate the rationale for their treatment approach concisely to the patient and modify the treatment plan as circumstances change
    Course summary
    Available credit: 
    • 25.50 AMA PRA Category 1 Credit™
    • 25.50 Non-Physician Participation
    Course opens: 
    03/17/2016
    Course expires: 
    06/14/2019
    Event starts: 
    06/11/2016 - 7:00am
    Event ends: 
    06/14/2016 - 8:00pm
    Price:
    $695.00
    Rating: 
    0

    Saturday, June 11, 2016

    6:45 – 8:00 am                  Continental Breakfast and Registration

    8:00 – 8:15 am                  Welcome, Introduction                                

    Session: Nephrolithiasis and Advanced Prostate Cancer

    8:15 – 9:15 am                 Nephrolithiasis 1: The Physiology of Stones

                                                Glenn M. Preminger, MD

    9:15 – 10:15 am              Nephrolithiasis 2: Metabolic Work-up and Treatment of Stones

                                                Glenn M. Preminger, MD

    10:15 – 10:30 am             Break

    10:30 – 11:30 am            Management of Advanced Prostate Cancer: Drugs, Mechanisms, Disease, Epidemiology and                                                              Molecular Mechanisms

                                                 Michael B. Williams, MD

    11:30 – 11:45 am             AUA Update: Core Curriculum

                                                 Victor Nitti, MD

    11:45 am – 12:45 pm      Lunch & Learn with the Experts

    Session: Incontinence, Infections, and Pelvic Pain

    12:45 – 1:45 pm                Pelvic Organ Prolapse and SUI: Mechanisms and Mechanics

                                                  Catherine Matthews, MD                            

    1:45 – 2:45 pm                  UTIs: Pattern and Pathophysiology

                                                  Michael A. Liss, MD, MAS

    2:45 – 3:00 pm                  Break

    3:00 – 4:00 pm                  Interstitial Cystitis and Disorders of Pelvic Pain

                                                  Robert J. Evans, MD, FACS

    4:00 – 4:30 pm                  Q&A Session

    5:30 – 7:00 pm                  Reception

    Sunday, June 12, 2016

    7:00 – 8:00 am                  Continental Breakfast

    Session: Minimally Invasive Surgery, BPH, Ethics, and Renal Oncology

    8:00 – 9:00 am                  Lasers, Laparoscopes, and Lithotripters: The Science of Minimally Invasive

                                                    Urology

                                                    Jay D. Raman, MD

    9:00 – 10:00 am             BPH and LUTS in Men: Pathophysiology and Evaluation

                                                Richard K. Lee, MD

    10:00 – 10:15 am             Break

    10:15 – 11:15 am             Uro-Ethics

                                                 Eric A. Singer, MD

    11:15 am – 12:45 pm      Molecular Genetics and Principles of Molecular Therapeutics of Kidney Cancer

                                                 W. Marston Linehan, MD

    12:45 – 1:45 pm                Lunch & Learn with the Experts

    Session: Outcomes Research and Imaging

    1:45 – 2:45 pm                  Application of Outcomes Research to Urologic Patients

                                                 Charles D. Scales Jr., MD

    2:45– 3:00 pm                   Break                   

    3:00 – 4:00 pm                  MRI for Urologists

                                                Afshan Ornan, MD

    4:00 – 4:15 pm                  Q&A Session

    Monday, June 13, 2016

    7:15 – 8:15 am                  Continental Breakfast

    Session:  Adrenal and Renal Physiology and Bowel Diversions

    8:15 – 9:15 am                Adrenal Physiology

                                               Paul L. Crispen, MD

    9:15 – 10:15 am              Bowel Diversions: Physiology Underlying Electrolyte Abnormalities

                                                Tracey L. Krupski, MD, MPH

    10:15 – 10:30 am             Break

    10:30 – 11:30 am             Renal Physiology Changes in Pathologic States

                                                 Necole Marie Streeper, MD

    Session: The Bladder and Male Infertility

    11:30 am – 12:30 pm      Basic Science of Bladder Cancer

                                                 Trinity J. Bivalacqua, MD, PhD

    12:30 – 1:30 pm                Lunch & Learn with the Experts

    1:30 – 1:45 pm                  AUA Update: Office of Research

    1:45 – 3:15 pm                  Bladder Pharmacologic and the Neurogenic Bladder

                                                 Adam Philip Klausner, MD

    3:15 – 3:30 pm                  Break

    3:30 – 4:30 pm                  Male Infertility

                                                 Puneet Masson, MD

    4:30 – 4:45 pm                 Q&A Session

    Tuesday, June 14, 2016

    7:00 – 8:00 am                  Continental Breakfast  

    Session: Screening, Pediatrics, and Reproductive Biology

    8:00 – 9:00 am                  PSA, Urine Markers and the Science of Cancer Screening

                                                 Leonard G. Gomella, MD

    9:00 – 10:00 am                Intersex

                                                Duong D. Tu, MD

    10:00 – 10:15 am             Break

    10:15 – 11:15 am             Reproductive Biology and Sexual Dysfunction in Men and Women

                                                Raymond Anthony Costabile, MD

    Session: Pediatric Urology

    11:15 am – 12:15 pm      Obstructive Uropathy: Valves and UPJO

                                                    C.D. Anthony Herndon, MD, FAAP, FACS         

    12:15 – 1:15 pm                Embryology and Congenital Anomalies

                                                    Patricio C. Gargollo, MD

    Omni Charlottesville Hotel
    Charlottesville, VA
    United States

    Name

    Company

    Role

    Financial

    Trinity J. Bivalacqua, MD

    heat biologic

    Scientific Study or Trial

    No

    photocure

    Scientific Study or Trial

    No

    Raymond A. Costabile, MD

    Lilly/Icos

    Consultant or Advisor, Scientific Study or Trial

    No

    Vivus

    Scientific Study or Trial

    No

    Paul L. Crispen, M.D.

    Nothing to disclose.

    Robert J. Evans, MD

    allergan

    Scientific Study or Trial

    Yes

    urigen

    Investment Interest

    Yes

    allergan

    Scientific Study or Trial

    Yes

    TARIS

    Scientific Study or Trial

    Yes

    aquinox

    Consultant or Advisor, Scientific Study or Trial

    Yes

    Patricio C. Gargollo, MD

    Nothing to disclose.

    Leonard G. Gomella, MD

    Astellas

    Consultant or Advisor

    Yes

    Janssen

    Consultant or Advisor

    Yes

    Dendreon

    Consultant or Advisor, Scientific Study or Trial

    Yes

    Wolters Kluwer

    Health Publishing

    Yes

    McGraw Hill

    Health Publishing

    Yes

    Merck Manual

    Health Publishing

    Yes

    Canadian Journal of Urology

    Health Publishing

    Yes

    MDx Health

    Consultant or Advisor

    Yes

    Merck Pharmaceuticals

    Consultant or Advisor

    Yes

    Bayer

    Consultant or Advisor

    Yes

    Mikel L. Gray, Ph.D.

    Laborie Medical

    Meeting Participant or Lecturer

    Yes

    3M Inc.

    Consultant or Advisor

    Yes

    C.D. Anthony Herndon, MD, FAAP, FACS

    Nothing to disclose.

    Adam Philip Klausner, MD

    Nothing to disclose.

    Tracey Krupski, MD

    Argos

    Scientific Study or Trial

    No

    NCI- RAZOR

    Scientific Study or Trial

    No

    Richard K. Lee, MD

    Nothing to disclose

    W. Marston Linehan, MD

    Nothing to disclose.

    Michael A. Liss, MD

    Nothing to disclose.

    Puneet Masson, MD

    Nothing to disclose.

    Afshan Ornan ,M.D.

    Nothing to disclose.

    Gladell Paner, MD

    Nothing to disclose.

    Glenn M. Preminger, MD

    Boston Scientific

    Consultant or Advisor

    Yes

    Olympus

    Meeting Participant or Lecturer

    Yes

    Endourological Society

    Leadership Position

    Yes

    UpToDate

    Health Publishing

    Yes

    Retrophin

    Consultant or Advisor, Meeting Participant or Lecturer

    Yes

    Jay D. Raman, MD

    American Kidney Stone Management

    Investment Interest

    Yes

    Charles D. Scales Jr., MD

    NIH/National Institute on Aging

    Scientific Study or Trial

    Yes

    American Geriatrics Society

    Scientific Study or Trial

    Yes

    Society of Urology Chairpersons and Program Directors

    Scientific Study or Trial

    Yes

    Pfizer/National Comprehensive Cancer Network

    Scientific Study or Trial

    Yes

    Eric A. Singer, MD

    Nothing to disclose.

    Necole M Streeper, M.D.

    Nothing to disclose.

    Duong D. Tu, M.D.

    Nothing to disclose.

    Michael B. Williams, M.D.

    Astellas

    Consultant or Advisor

    Yes

    Jannsen

    Consultant or Advisor

    Yes

    Pacific Health Laboratories

    Consultant or Advisor

    Yes

    Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation:The American Urological Association designates this live activity for a maximum of 25.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

    Evidence-Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

    AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual's relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

    Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

    • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup
    • Limit content to evidence with no recommendations
    • Introduction of a debate format with an unbiased moderator (point-counterpoint)
    • Inclusion of moderated panel discussion
    • Publication of a parallel or rebuttal article for an article that is felt to be biased
    • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
    • Divestiture of the relationship by faculty

    Off-Label or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

    Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this program are their own and do not necessarily represent the viewpoint of the AUA.

    Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

    Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

    Special Assistance: The American Urological Association complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.


    Available Credit

    • 25.50 AMA PRA Category 1 Credit™
    • 25.50 Non-Physician Participation

    Accreditation Period

    Course opens: 
    03/17/2016
    Course expires: 
    06/14/2019

    Price

    Price:
    $695.00
    Please login or register to take this course.